Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival
European Journal of Surgical Oncology, 06/30/09
Hagendoorn J et al. - In a study to examine the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal carcinomatosis of colorectal and gastrointestinal origin, it was concluded that in well-selected pts referred to a specialized institution, CS–HIPEC has acceptable morbidity and high survival rate.
Methods- 67 pts underwent a laparotomy.
- Complete cytoreduction could be performed in 49 pts, who underwent 53 CS–HIPEC procedures.
- All had peritoneal carcinomatosis originating from primary colorectal, cecal, appendiceal, and gastric tumors.
- In pts who underwent CS–HIPEC, an R0 resection could be achieved in 4%, R1 in 88%, and R2 in 8%.
- 30-day mortality was 0; 1 pt died in-hospital after 10 wks.
- Median hospital stay was 12 days.
- Overall morbidity was 43%, including extended gastroparesis (11%), anastomotic failure (11%), and intra-abdominal abscess (9%).
- Mean time to clinical recurrence was 12 mos.
- Actuarial 1-yr survival was 88% and 2-yr survival was 75%.
Today in Colo-Rectal...keeping you current
Receive free subspecialty "5-minute updates" via email
Localized resection for colon cancer
Surgical Oncology, 11/04/09
Quality of surgery for rectal carcinoma: comparison between open and laparoscopic approaches
The American Journal of Surgery, 11/03/09
Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Today in Hernia/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of Fistulizing Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/13/09
Novel Pancreaticojejunostomy with a Low Rate of Anastomotic Failure-Related Complications
Journal of the American College of Surgeons, 10/30/09
Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery
Critical Care, 11/06/09
Today in Surgical Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Localized resection for colon cancer
Surgical Oncology, 11/04/09
Original contribution: surgeon recommendations and receipt of mastectomy for treatment of breast cancer
JAMA, 10/28/09
Quality of surgery for rectal carcinoma: comparison between open and laparoscopic approaches
The American Journal of Surgery, 11/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


